Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1,091,129,524
-
Total 13F shares
-
35,163,819
-
Share change
-
-7,407,378
-
Total reported value
-
$1,191,548,050
-
Put/Call ratio
-
131%
-
Price per share
-
$33.89
-
Number of holders
-
137
-
Value change
-
-$254,812,699
-
Number of buys
-
68
-
Number of sells
-
81
Institutional Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q3 2025
As of 30 Sep 2025,
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,163,819 shares.
The largest 10 holders included
Capital World Investors, FMR LLC, Clearbridge Investments, LLC, RTW INVESTMENTS, LP, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Frazier Life Sciences Management, L.P., BAMCO INC /NY/, CITADEL ADVISORS LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
137
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.